日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Different immunotherapeutic combinations enhance specific T cell immune responses against leukemic cells, as well as leukemic progenitor cells, in acute myeloid leukemia

不同的免疫治疗组合可增强急性髓系白血病中针对白血病细胞以及白血病祖细胞的特异性T细胞免疫反应。

Greiner, Jochen; Schuler, Patrick J; Schrezenmeier, Hubert; Weiss, Johanna; Bulach, Christiane; Goetz, Marlies; Guinn, Barbara-Ann

Overactivation of Cdc42 GTPase Impairs the Cytotoxic Function of NK Cells From Old Individuals Towards Senescent Fibroblasts.

Cdc42 GTPase 过度激活会损害老年人 NK 细胞对衰老成纤维细胞的细胞毒性功能。

Koroma Albert Kallon, Singh Karmveer, Wang Yongfang, Krug Linda, Haas Philipp, Wlaschek Meinhard, Sakk Vadim, Schuster Tanja, Fürst Daniel, Schrezenmeier Hubert, Dheenadayalan Rashmi Priyadharshini, Stilgenbauer Stephan, Walter Lutz, Geiger Hartmut, Scharffetter-Kochanek Karin, Maity Pallab

Immune checkpoint inhibition increases antigen-specific T cell response in head and neck cancer

免疫检查点抑制剂可增强头颈癌中抗原特异性T细胞反应。

Schuler, Patrick J; Oliveri, Franziska; Puntigam, Lisa; Six, Klara; Kaißer, Carlotta; Maier, Julia; Laban, Simon; von Witzleben, Adrian; Brunner, Cornelia; Messerer, David A C; Schrezenmeier, Hubert; Hoffmann, Thomas K; Goetz, Marlies; Greiner, Jochen

Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH

达尼可泮作为拉武利珠单抗或依库珠单抗的附加疗法,用于治疗伴有显著EVH的阵发性睡眠性血红蛋白尿症(PNH)的长期疗效和安全性

Kulasekararaj, Austin; Griffin, Morag; Piatek, Caroline; Shammo, Jamile; Nishimura, Jun-Ichi; Patriquin, Christopher; Schrezenmeier, Hubert; Barcellini, Wilma; Panse, Jens; Gaya, Anna; Patel, Yogesh; Liu, Peng; Filippov, Gleb; Sicre de Fontbrune, Flore; Risitano, Antonio; Lee, Jong Wook

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial

对轻症 COVID-19 临床易感人群早期应用高滴度康复者血浆疗法:一项国际性、随机、开放标签试验

Hoffmann, Simone; Schrezenmeier, Eva; Desmarets, Maxime; Halleck, Fabian; Durrbach, Antoine; Peters, Lynn; Tremmel, Anna-Teresa; Seidel, Alina; Führer, Marita; Bachmann, Friederike; Schrezenmeier, Jens; Greiner, Jochen; Körper, Sixten; Hofmann, Henrike; Ludwig, Carolin; Vieweg, Christiane; Jahrsdörfer, Bernd; Budde, Klemens; Schmidt, Michael; Münch, Jan; Joher, Nizar; Daguindau, Etienne; Grüner, Beate; Brunotte, Gaëlle; Vauchy, Charline; Seifried, Erhard; Bradshaw, Daniel; Estcourt, Lise J; Roberts, David J; Toussirot, Eric; Rijnders, Bart; Tiberghien, Pierre; Schrezenmeier, Hubert

RAG recombinase expression discriminates the development of natural killer cells

RAG重组酶的表达决定了自然杀伤细胞的发育。

Sprissler, Jasmin; Pannicke, Ulrich; Rump, Eva-Maria; Schrezenmeier, Hubert; Casadei, Nicolas; Pogoda, Michaela; Kuhlburger, Laurence; Oquendo, Morgana Barroso; Czemmel, Stefan; Debatin, Klaus-Michael; Erlacher, Miriam; Schwarz, Klaus; Felgentreff, Kerstin

Effective cellular and neutralizing immunity against SARS-CoV-2 after mRNA booster vaccination is associated with pDC and B cell activation

mRNA加强疫苗接种后,针对SARS-CoV-2的有效细胞免疫和中和免疫与浆细胞样树突状细胞(pDC)和B细胞活化相关。

Fabricius, Dorit; Ludwig, Carolin; Proffen, Matthias; Hägele, Janina; Scholz, Judith; Vieweg, Christiane; Rode, Immanuel; Hoffmann, Simone; Körper, Sixten; Schrezenmeier, Hubert; Jahrsdörfer, Bernd

Bone Augmentation of Atrophic Alveolar Ridges Using a Synthetic Bone Substitute With Mesenchymal Stem Cells: A Randomized, Controlled Clinical Trial

使用含间充质干细胞的合成骨替代材料进行萎缩性牙槽嵴骨增量术:一项随机对照临床试验

Sanz, Mariano; Gjerde, Cecilie; Gjertsen, Bjørn Tore; Ortiz-Vigón, Alberto; Sanchez, Nerea; Hoornaert, Alain; Caballe-Serrano, Jordi; Giralt-Hernando, Maria; Gaultier, Frederick; Reinald, Nicoleta; Pinholt, Else Marie; Rojewski, Markus; Rouard, Helen; Chevallier, Nathalie; Mohamed-Ahmed, Samih; Shi, Xieqi; Shi, Tie-Jun; Schrezenmeier, Hubert; Layrolle, Pierre; Mustafa, Kamal

AK2-Deficient Mice Recapitulate Impaired Lymphopoiesis of Reticular Dysgenesis Patients, but Also Lack Erythropoiesis

AK2缺陷小鼠重现了网状组织发育不全患者的淋巴细胞生成障碍,但也缺乏红细胞生成。

Waldmann, Rebekka; Werner, Franziska; Tasdogan, Alpaslan; Maier, Felix Immanuel; Kohlhofer, Ursula; Gonzalez-Menendez, Irene; de Fend, Leticia Quintanilla; Puarr, Amrit Kaur; Arkell, Ruth Maree; Enders, Anselm; Hoenig, Manfred; Schrezenmeier, Hubert; Fehling, Hans Joerg; Schwarz, Klaus; Pannicke, Ulrich

Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria

Ravulizumab 在阵发性睡眠性血红蛋白尿症患者中显示出长期疗效、安全性和良好的患者生存率。

Kulasekararaj, Austin; Brodsky, Robert; Schrezenmeier, Hubert; Griffin, Morag; Röth, Alexander; Piatek, Caroline; Ogawa, Masayo; Yu, Ji; Patel, Ami S; Patel, Yogesh; Notaro, Rosario; Usuki, Kensuke; Kulagin, Alexander; Gualandro, Sandra; Füreder, Wolfgang; Peffault de Latour, Regis; Szer, Jeff; Lee, Jong Wook